Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginNet MarginOperating MarginReturn on Sales

ENDRA Life Sciences (NDRA) Return on Capital Employed (2017 - 2021)

ENDRA Life Sciences (NDRA) has disclosed Return on Capital Employed for 5 consecutive years, with 0.73% as the latest value for Q3 2021.

  • Quarterly Return on Capital Employed rose 384.0% to 0.73% in Q3 2021 from the year-ago period, while the trailing twelve-month figure was 0.73% through Sep 2021, up 384.0% year-over-year, with the annual reading at 1.65% for FY2020, 47.0% up from the prior year.
  • Return on Capital Employed for Q3 2021 was 0.73% at ENDRA Life Sciences, down from 0.69% in the prior quarter.
  • The five-year high for Return on Capital Employed was 1.26% in Q1 2017, with the low at 6.27% in Q3 2019.
  • Average Return on Capital Employed over 5 years is 2.07%, with a median of 1.37% recorded in 2021.
  • The sharpest move saw Return on Capital Employed plummeted -197bps in 2018, then surged 423bps in 2021.
  • Over 5 years, Return on Capital Employed stood at 0.78% in 2017, then tumbled by -254bps to 2.75% in 2018, then dropped by -19bps to 3.26% in 2019, then surged by 42bps to 1.89% in 2020, then skyrocketed by 62bps to 0.73% in 2021.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.73%, 0.69%, and 0.84% for Q3 2021, Q2 2021, and Q1 2021 respectively.